Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kayo, T.
Right arrow Articles by Takeuchi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kayo, T.
Right arrow Articles by Takeuchi, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 8 1296-1304, Copyright © 1997 by American Diabetes Association


ARTICLES

Proprotein-processing endoprotease furin controls growth of pancreatic beta-cells

T Kayo, Y Sawada, M Suda, Y Konda, T Izumi, S Tanaka, H Shibata and T Takeuchi
Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

We have previously reported that in the well-differentiated beta-cell line MIN6 cells, the beta-cell-specific differentiated characteristics, such as insulin content, expression of prohormone convertases PC2 and PC3, and glucose-regulated insulin secretion, diminished when the proprotein-processing endoprotease furin was highly expressed. Since furin converts many growth-related protein precursors to their bioactive forms, we compared the four pancreatic islet cell lines RINm5F, betaTC3, betaHC9, and MIN6 with respect to cell growth rate, furin expression, endoprotease activity, and insulin content. RINm5F cells exhibited the strongest furin expression, higher furin-type endoprotease activity, and the fastest cell growth, but had the least insulin content. In contrast, MIN6 cells exhibited only a weak furin expression, little furin-type endoprotease activity, and the slowest cell growth, but had the highest insulin content. To test whether furin-expressing cells secrete growth-promoting factors cleaved by furin, we prepared conditioned media from RINm5F and furin cDNA-introduced MIN6 (MIN6-F) cells. The conditioned media from RINm5F and MIN6-F induced increased DNA synthesis and promoted the growth of normal MIN6 cells, compared with the medium from the empty vector-introduced MIN6-0 cells. We then examined the effect of the protease inhibitors alpha1-antitrypsin and its variants by infecting their vaccinia recombinants to the four cell lines. All conditioned media from each cell line expressing the furin-specific alpha1-antitrypsin variant exhibited the least DNA synthetic capacity on normal MIN6 cells. Furthermore, all three sublines of MIN6-F grew faster than MIN6-0 and MIN6. Thus, we suggest that the islet cells with higher furin expression may induce increased production of growth factors, which result in an increase in cell growth, through an autocrine/paracrine mechanism.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
H Wang, Y Horikawa, L Jin, T Narita, S Yamada, N Shihara, K Tatemoto, M Muramatsu, T Mune, and J Takeda
Gene expression profile in rat pancreatic islet and RINm5F cells
J. Mol. Endocrinol., August 1, 2005; 35(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Zhang, M. Hosaka, Y. Sawada, S. Torii, S. Mizutani, M. Ogata, T. Izumi, and T. Takeuchi
Parathyroid Hormone-Related Protein Induces Insulin Expression Through Activation of MAP Kinase-Specific Phosphatase-1 That Dephosphorylates c-Jun NH2-Terminal Kinase in Pancreatic {beta}-Cells
Diabetes, November 1, 2003; 52(11): 2720 - 2730.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. E. Bassi, H. Mahloogi, R. Lopez De Cicco, and A. Klein-Szanto
Increased Furin Activity Enhances the Malignant Phenotype of Human Head and Neck Cancer Cells
Am. J. Pathol., February 1, 2003; 162(2): 439 - 447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A.-M. Khatib, G. Siegfried, M. Chretien, P. Metrakos, and N. G. Seidah
Proprotein Convertases in Tumor Progression and Malignancy : Novel Targets in Cancer Therapy
Am. J. Pathol., June 1, 2002; 160(6): 1921 - 1935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, T. Takeuchi, H. Yokota, and T. Izumi
Novel Rabphilin-3-like Protein Associates with Insulin-containing Granules in Pancreatic Beta Cells
J. Biol. Chem., October 1, 1999; 274(40): 28542 - 28548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-M. Khatib, G. Siegfried, A. Prat, J. Luis, M. Chretien, P. Metrakos, and N. G. Seidah
Inhibition of Proprotein Convertases Is Associated with Loss of Growth and Tumorigenicity of HT-29 Human Colon Carcinoma Cells. IMPORTANCE OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) RECEPTOR PROCESSING IN IGF-1-MEDIATED FUNCTIONS
J. Biol. Chem., August 10, 2001; 276(33): 30686 - 30693.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.